Biofil Chemicals and Pharmaceuticals Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Biofil Chemicals and Pharmaceuticals Limited's balance sheet done over the years? Its assets were worth $470,827,000 last year, which is more than in the previous period. 61% of Biofil Chemicals and Pharmaceuticals Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $288,799,000, which means an increase by 1424% compared compared to last year.
Debt to Assets
| 2011 | 103810819 | 36.79M | 35.44% |
|---|---|---|---|
| 2012 | 141089173 | 72.72M | 51.55% |
| 2015 | 137562825 | 53.41M | 38.83% |
| 2016 | 241319409 | 132.25M | 54.8% |
| 2018 | 241547000 | 109.87M | 45.49% |
| 2019 | 242130000 | 105.63M | 43.63% |
| 2020 | 423647000 | 274.81M | 64.87% |
| 2021 | 332384000 | 171.09M | 51.47% |
| 2022 | 187322000 | 18.94M | 10.11% |
| 2024 | 470827000 | 288.79M | 61.34% |
BIOFILCHEM.NS Balance Sheet (2011 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 22.83M | 1.45M | 4.40M | 2.56M | 1.36M | 3.74M | 1.80M | 1.27M | 2.54M | 899.67K |
Short term investments | 21.90M | 600K | 4.30M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net receivables | 330.29M | 76.27M | 186.76M | 299.24M | 121.92M | 129.80M | 139.84M | 36.51M | 0 | 0 |
Inventory | 25.49M | 12.93M | 43.44M | 16.92M | 11.90M | 10.24M | 960.22K | 1.66M | 2.18M | 630.46K |
Other current assets | 5.45M | 2.47M | -1K | 303.24M | 125.91M | 5.27M | 10.07M | 7.53M | 45.36M | 17.40M |
Total current assets | 384.07M | 93.13M | 234.61M | 322.72M | 139.18M | 149.07M | 151.56M | 47.26M | 50.09M | 18.93M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 86.24M | 94.19M | 97.76M | 100.92M | 102.94M | 92.46M | 89.75M | 90.57M | 90.99M | 84.87M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 508K | -191K | -37K | -100.92M | -102.94M | -1K | 0 | -280K | -1 | 0 |
Total non-current assets | 86.75M | 94.19M | 97.76M | 100.92M | 102.94M | 92.46M | 89.75M | 90.29M | 90.99M | 84.87M |
Total assets | 470.82M | 187.32M | 332.38M | 423.64M | 242.13M | 241.54M | 241.31M | 137.56M | 141.08M | 103.81M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 4.33M | -4.29M | -11.92M | -16.37M | 2.87M | 0 | 0 | 0 | 0 |
Short term debt | 4.38M | 4.64M | 4.29M | 11.92M | 16.37M | 15.58M | 13.69M | 29.80M | 24.89M | 0 |
Total current liabilities | 285.24M | 14.94M | 167.53M | 274.81M | 105.63M | 109.87M | 132.25M | 53.41M | 72.72M | 23.81M |
| Non-current liabilities: | ||||||||||
Long term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.97M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 0 | 0 | -1K | 0 | -1K | 1 | 0 | 1 | -1 |
Total non-current liabilities | 3.55M | 3.99M | 3.56M | -1K | 0 | -1K | 1 | 0 | 1 | 12.97M |
Total liabilities | 288.79M | 18.94M | 171.09M | 274.81M | 105.63M | 109.87M | 132.25M | 53.41M | 72.72M | 36.79M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |